Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
Investors Ignore Increasing Losses at Twist Bioscience (NASDAQ:TWST) as Stock Jumps 12% This Past Week
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
Twist Bioscience Corporation (TWST): Among the Worst ARK Stocks According to Short Sellers
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
Top Premarket Gainers
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)
Twist Bioscience Corporation's (NASDAQ:TWST) Prospects Need A Boost To Lift Shares
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
Analysts Have Conflicting Sentiments on These Healthcare Companies: Merus (MRUS), Twist Bioscience (TWST) and Owens & Minor (OMI)
Scotiabank Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $50
Scotiabank analyst Sung Ji Nam maintains $Twist Bioscience(TWST.US)$ with a buy rating, and adjusts the target price from $48 to $50.According to TipRanks data, the analyst has a success rate of 47.6%
Scotiabank Remains a Buy on Twist Bioscience (TWST)
Express News | Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $55
Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday
Twist Bioscience Price Target Raised to $35.00/Share From $28.00 by JP Morgan
Twist Bioscience Is Maintained at Underweight by JP Morgan
Twist Bioscience And BitBiome Announced The Launch Of A Joint Transaminase Enzyme Screening Kit
Express News | Twist Bioscience and Bitbiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
Baird Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $46
Baird analyst Catherine Ramsey Schulte maintains $Twist Bioscience(TWST.US)$ with a buy rating, and adjusts the target price from $40 to $46.According to TipRanks data, the analyst has a success